Recall of five batches of Bepraz Gastro Resistant Tablet 20mg (rabeprazole)

The Health Sciences Authority (HSA) would like to inform healthcare professionals of a voluntary consumer level recall of Bepraz Gastro Resistant Tablet 20mg (‘Bepraz’) initiated by the manufacturer, Sun Pharmaceutical Industries Limited. The recall is a precautionary measure due to detection of low levels of an impurity, a degradation by-product of the active ingredient rabeprazole sodium, in one batch of Bepraz. The company is recalling all five batches of Bepraz currently available in the market to prevent potential exposure of patients to elevated impurity levels. Please refer to the letter for details.
Healthcare professional, Industry member, Therapeutic Products
Published:

Dear Healthcare Professional Letters

25 Aug 2025

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.

Step 1: Select your profession under 'For Healthcare Professionals’.

Step 2: Click on 'Restricted Content' and log in via SingPass.

Step 3: Click on the MOH Alert icon under ‘Applications’.

Step 4: Click on the Drug Alert tab to view the DHCPLs.